Tackling deadly newborn disease, BridgeBio affiliate wins FDA drug approval For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | February 26, 2021 The BridgeBio model is designed to move drugs tackling rare diseases with a well-defined genetic basis quickly and efficiently to approval. Posted in Sacramento Business Journal